| Tài liệu tham khảo |
Loại |
Chi tiết |
| 12. American Society of Health-System Pharmacists (2011), "Meropenem (Systemic)", AHFS DRUG INFORMATION, Bethesda, Maryland, pp |
Sách, tạp chí |
| Tiêu đề: |
Meropenem (Systemic) |
| Tác giả: |
American Society of Health-System Pharmacists |
| Năm: |
2011 |
|
| 13. Blassmann U., Roehr A. C., et al. (2016), "Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study", Crit Care, 20(1), pp. 343 |
Sách, tạp chí |
| Tiêu đề: |
Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study |
| Tác giả: |
Blassmann U., Roehr A. C., et al |
| Năm: |
2016 |
|
| 14. Blot S. I., Pea F., et al. (2014), "The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents", Adv Drug Deliv Rev, 77, pp. 3-11 |
Sách, tạp chí |
| Tiêu đề: |
The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents |
| Tác giả: |
Blot S. I., Pea F., et al |
| Năm: |
2014 |
|
| 15. Boucher B. A., Wood G. C., et al. (2006), "Pharmacokinetic changes in critical illness", Crit Care Clin, 22(2), pp. 255-71, vi |
Sách, tạp chí |
| Tiêu đề: |
Pharmacokinetic changes in critical illness |
| Tác giả: |
Boucher B. A., Wood G. C., et al |
| Năm: |
2006 |
|
| 16. Bradley J. S., Garau J., et al. (1999), "Carbapenems in clinical practice: a guide to their use in serious infection", Int J Antimicrob Agents, 11(2), pp. 93-100 |
Sách, tạp chí |
| Tiêu đề: |
Carbapenems in clinical practice: a guide to their use in serious infection |
| Tác giả: |
Bradley J. S., Garau J., et al |
| Năm: |
1999 |
|
| 17. Braune S., Konig C., et al. (2018), "Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study", Crit Care, 22(1), pp. 25 |
Sách, tạp chí |
| Tiêu đề: |
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study |
| Tác giả: |
Braune S., Konig C., et al |
| Năm: |
2018 |
|
| 18. Charles Bruce (2014), "Population pharmacokinetics: an overview", Australian Prescriber, 37(6), pp |
Sách, tạp chí |
| Tiêu đề: |
Population pharmacokinetics: an overview |
| Tác giả: |
Charles Bruce |
| Năm: |
2014 |
|
| 19. Chen W., Zhang D., et al. (2020), "Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation", Antimicrob Agents Chemother, 64(6), pp |
Sách, tạp chí |
| Tiêu đề: |
Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation |
| Tác giả: |
Chen W., Zhang D., et al |
| Năm: |
2020 |
|
| 20. Chung E. K., Cheatham S. C., et al. (2017), "Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients", J Clin Pharmacol, 57(3), pp. 356-368 |
Sách, tạp chí |
| Tiêu đề: |
Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients |
| Tác giả: |
Chung E. K., Cheatham S. C., et al |
| Năm: |
2017 |
|
| 21. Cojutti P., Sartor A., et al. (2017), "Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae", Antimicrob Agents Chemother, 61(10), pp |
Sách, tạp chí |
| Tiêu đề: |
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae |
| Tác giả: |
Cojutti P., Sartor A., et al |
| Năm: |
2017 |
|
| 23. Couffignal C., Pajot O., et al. (2014), "Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens", Br J Clin Pharmacol, 78(5), pp. 1022-34 |
Sách, tạp chí |
| Tiêu đề: |
Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens |
| Tác giả: |
Couffignal C., Pajot O., et al |
| Năm: |
2014 |
|
| 24. Crandon J. L., Ariano R. E., et al. (2011), "Optimization of meropenem dosage in the critically ill population based on renal function", Intensive Care Med, 37(4), pp. 632-8 |
Sách, tạp chí |
| Tiêu đề: |
Optimization of meropenem dosage in the critically ill population based on renal function |
| Tác giả: |
Crandon J. L., Ariano R. E., et al |
| Năm: |
2011 |
|
| 25. Crandon J. L., Kuti J. L., et al. (2009), "Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance", Ann Pharmacother, 43(2), pp. 220-7 |
Sách, tạp chí |
| Tiêu đề: |
Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance |
| Tác giả: |
Crandon J. L., Kuti J. L., et al |
| Năm: |
2009 |
|
| 26. David Shen Alps Biostatistics Inc., Zaizai Lu AstraZeneca Pharmaceuticals (2007), Population Pharmacokinetics Studies with Nonlinear Mixed Effects Modeling, pp.148-2007 |
Sách, tạp chí |
| Tiêu đề: |
Population Pharmacokinetics Studies with Nonlinear Mixed Effects Modeling |
| Tác giả: |
David Shen Alps Biostatistics Inc., Zaizai Lu AstraZeneca Pharmaceuticals |
| Năm: |
2007 |
|
| 27. de Velde F., Mouton J. W., et al. (2018), "Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives", Pharmacol Res, 134, pp. 280-288 |
Sách, tạp chí |
| Tiêu đề: |
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives |
| Tác giả: |
de Velde F., Mouton J. W., et al |
| Năm: |
2018 |
|
| 28. Delattre Maud, Lavielle Marc, et al. (2014), "A note on BIC in mixed-effects models", Electronic Journal of Statistics, 8, pp |
Sách, tạp chí |
| Tiêu đề: |
A note on BIC in mixed-effects models |
| Tác giả: |
Delattre Maud, Lavielle Marc, et al |
| Năm: |
2014 |
|
| 29. Doh K., Woo H., et al. (2010), "Population pharmacokinetics of meropenem in burn patients", J Antimicrob Chemother, 65(11), pp. 2428-35 |
Sách, tạp chí |
| Tiêu đề: |
Population pharmacokinetics of meropenem in burn patients |
| Tác giả: |
Doh K., Woo H., et al |
| Năm: |
2010 |
|
| 30. Dreetz M., Hamacher J., et al. (1996), "Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin", Antimicrob Agents Chemother, 40(1), pp. 105-9 |
Sách, tạp chí |
| Tiêu đề: |
Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin |
| Tác giả: |
Dreetz M., Hamacher J., et al |
| Năm: |
1996 |
|
| 31. Drusano G. L., Standiford H. C., et al. (1984), "Multiple-dose pharmacokinetics of imipenem-cilastatin", Antimicrob Agents Chemother, 26(5), pp. 715-21 |
Sách, tạp chí |
| Tiêu đề: |
Multiple-dose pharmacokinetics of imipenem-cilastatin |
| Tác giả: |
Drusano G. L., Standiford H. C., et al |
| Năm: |
1984 |
|
| 32. Ette E. I., Williams P. J., et al. (2004), "Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies", Ann Pharmacother, 38(12), pp. 2136-44 |
Sách, tạp chí |
| Tiêu đề: |
Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies |
| Tác giả: |
Ette E. I., Williams P. J., et al |
| Năm: |
2004 |
|
